James Lightwood, PhD

Associate Professor
Eric Davila
Phone: +1 415 514-0939
Fax: +1 415 502-0792


What I do

My research focuses on the economics, cost-effectiveness analysis, and cost-benefit analysis of public health programs. I am particularly interested in the economics of tobacco control and prevention of chronic illness.

Departmental research area

My research expertise

health economics, mathematical modeling, statistics, econometrics health statistics

Professional background


James M. Lightwood is an Associate Adjunct Professor, with emphasis on Health Economics and Statistics, in the Department of Clinical Pharmacy at the University of California, San Francisco. He is also affiliated with the Center for Tobacco Control, Research and Education, funded by the Legacy Foundation. His research currently focuses on the health and economic effects of tobacco smoking cessation and prevention, the cost of treatment of pediatric HIV-AIDS patients, and the economics of control of contagious disease. He is currently the Principal Investigator on a California Tobacco Related Disease Research Program funded grant on the medical cost savings to society and managed care providers following smoking cessation in adults. James is also working on models of disease progression for an NIH funded grant to estimate the cost of care-giving to children with HIV/AIDS infections. His work has been published in JAMA, Circulation, Pediatrics, Journal of Surgical Oncology and the Journal of Medical Screening. He has also published book chapters on the cost of smoking in developed and less developed countries. He has been a consultant to the World Health Organization on the economics of tobacco smoking and control in less developed countries. Dr. Lightwood teaches a project research seminar for fourth year pharmacy students in the Health Services and Policy Research Pathway.

Research keywords

  • Tobacco Use
  • Tobacco Products
  • Smoking
  • Health Expenditures
  • Health Promotion
  • smoking cessation
  • Drug Packaging
  • Housing
  • Tobacco Smoke Pollution
  • Coronary Disease
  • Smoking Prevention
  • health care costs
  • Drug Labeling
  • Financing, Personal
  • Healthcare Financing